Recent studies have suggested that glutamine and GLS1 activity are required for optimal growth of breast cancer cell lines in vitro and in vivo[47], [48] and additional work will clarify whether mesenchymal markers predict sensitivities to GLS inhibition in this population. The gene discussed is GLS; the disease is breast cancer.